KPIs & Operating Metrics(New)
Growth Metrics

Abbott Laboratories (ABT) Total Current Liabilities (2016 - 2025)

Abbott Laboratories' Total Current Liabilities history spans 17 years, with the latest figure at $16.5 billion for Q4 2025.

  • For Q4 2025, Total Current Liabilities rose 16.52% year-over-year to $16.5 billion; the TTM value through Dec 2025 reached $16.5 billion, up 16.52%, while the annual FY2025 figure was $16.5 billion, 16.52% up from the prior year.
  • Total Current Liabilities for Q4 2025 was $16.5 billion at Abbott Laboratories, up from $14.6 billion in the prior quarter.
  • Across five years, Total Current Liabilities topped out at $16.5 billion in Q4 2025 and bottomed at $12.4 billion in Q2 2022.
  • The 5-year median for Total Current Liabilities is $13.6 billion (2024), against an average of $13.8 billion.
  • The largest annual shift saw Total Current Liabilities increased 25.45% in 2021 before it dropped 10.64% in 2023.
  • A 5-year view of Total Current Liabilities shows it stood at $13.1 billion in 2021, then rose by 18.19% to $15.5 billion in 2022, then decreased by 10.64% to $13.8 billion in 2023, then rose by 2.28% to $14.2 billion in 2024, then grew by 16.52% to $16.5 billion in 2025.
  • Per Business Quant, the three most recent readings for ABT's Total Current Liabilities are $16.5 billion (Q4 2025), $14.6 billion (Q3 2025), and $13.4 billion (Q2 2025).